• Explore /
  • Poster
  • / A phase 2 study of BGJ398 in patients (pts) with advanced or metastatic FGFR-altered cholangiocarcinoma (CCA) who failed or are intolerant to platinum-based chemotherapy.

A phase 2 study of BGJ398 in patients (pts) with advanced or metastatic FGFR-altered cholangiocarcinoma (CCA) who failed or are intolerant to platinum-based chemotherapy.

Abstract Poster

Authors

null

Milind M. Javle

The University of Texas MD Anderson Cancer Center, Houston, TX

Milind M. Javle , Rachna T. Shroff , Andrew Zhu , Saeed Sadeghi , SuPin Choo , Mitesh J. Borad , Maeve Aine Lowery , Anthony El-Khoueiry , Teresa Macarulla , Philip Agop Philip , Do-Youn Oh , Eric Van Cutsem , Kun-Huei Yeh , Randi Isaacs , Carolyn McGarry , Suman Sen , Tanios S. Bekaii-Saab

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2016 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Sub Track

Multidisciplinary Treatment

Clinical Trial Registration Number

NCT02150967

Citation

J Clin Oncol 34, 2016 (suppl 4S; abstr 335)

DOI

10.1200/jco.2016.34.4_suppl.335

Abstract #

335

Poster Bd #

G15

Abstract Disclosures

Similar Posters

First Author: Junji Furuse

First Author: Milind M. Javle

First Author: Ghassan K. Abou-Alfa

First Author: Joon Oh Park